EarningsQ2 2024 Earnings Report

Axsome Therapeutics (19X) Q2 2024 Earnings Report

5 Followers

DE:19X Q2 2024 EPS Results

Actual EPS-€1.49

Consensus EPS-€1.17

Beat/MissMissed by -€0.32

One Year Ago EPS-€1.37

Actual Revenue€77.79M

Expected Revenue€77.57M

Beat/MissBeat by +€218.64K

YoY Revenue Growth+86.65%

QuarterQ2 2024

Date08/05/2024

TimeBefore Open

Conference CallMonday, August 5, 2024

DE:19X Upcoming Earnings

Axsome Therapeutics's next earnings date is estimated for November 2, 2026, based on past reporting schedules.

DE:19X Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 02, 2026	2026 (Q3)	-0.57 / -	-0.839	―
Aug 10, 2026	2026 (Q2)	-0.80 / -0.88	-0.866	-2.06% (-0.02)
May 04, 2026	2026 (Q1)	-0.75 / -1.12	-1.089	-3.28% (-0.04)
Feb 23, 2026	2025 (Q4)	-0.62 / -0.50	-1.374	63.64% (+0.87)
Nov 03, 2025	2025 (Q3)	-0.77 / -0.84	-1.196	29.85% (+0.36)
Aug 04, 2025	2025 (Q2)	-0.94 / -0.87	-1.49	41.92% (+0.62)
May 05, 2025	2025 (Q1)	-1.21 / -1.09	-1.285	15.28% (+0.20)
Feb 18, 2025	2024 (Q4)	-0.89 / -1.37	-1.856	25.96% (+0.48)
Nov 12, 2024	2024 (Q3)	-1.23 / -1.20	-1.178	-1.52% (-0.02)
Aug 05, 2024	2024 (Q2)	-1.17 / -1.49	-1.374	-8.44% (-0.12)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed